Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer
Author:
Publisher
Elsevier
Reference173 articles.
1. Emerging novel therapies in the treatment of castrate-resistant prostate cancer;Abdulla;Canadian Urological Association Journal,2011
2. Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease;Acloque;The Journal of Clinical Investigation,2009
3. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor;Andersen;Cancer Cell,2010
4. Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: Time to learn from past experiences;Antonarakis;Journal of Clinical Oncology,2013
5. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer;Antonarakis;The New England Journal of Medicine,2014
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer on motors: How kinesins drive prostate cancer progression?;Biochemical Pharmacology;2024-06
2. ATPase Copper Transporting Beta (ATP7B) Is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer;Molecular Cancer Therapeutics;2024-02-28
3. Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments;Cancers;2023-10-19
4. ELK1/KIFC1 axis promotes breast cancer cell proliferation by regulating glutathione metabolism;Journal of Obstetrics and Gynaecology Research;2023-06-20
5. Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration‐resistant prostate cancer;The Prostate;2023-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3